WallStreetZenWallStreetZen

NASDAQ: IMGN
Immunogen Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for IMGN

Based on 7 analysts offering 12 month price targets for Immunogen Inc.
Min Forecast
$4.00-22.93%
Avg Forecast
$11.86+128.46%
Max Forecast
$20.00+285.36%

Should I buy or sell IMGN stock?

Based on 7 analysts offering ratings for Immunogen Inc.
Buy
Strong Buy
3 analysts 42.86%
Buy
2 analysts 28.57%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IMGN stock forecasts and price targets.

IMGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Truist Securities
Bottom 20%
20
Strong BuyInitiates Coverage On$10.00+92.68%2022-11-21
Canaccord Genuity
Bottom 13%
13
Strong BuyMaintains$15.00+189.02%2022-11-16
BMO Capital
Top 11%
90
BuyMaintains$19.00+266.09%2022-11-16
HC Wainwright & Co.
Bottom 4%
4
BuyMaintains$20.00+285.36%2022-11-16
Barclays
Bottom 11%
11
Strong BuyMaintains$9.00+73.41%2022-11-15
SVB Leerink
Bottom 2%
2
HoldMaintains$4.00-22.93%2022-05-06
RBC Capital
Bottom 23%
23
HoldDowngrades$6.00+15.61%2022-03-21

1 of 1

Forecast return on equity

Is IMGN forecast to generate an efficient return?
Company
35.96%
Industry
13.69%
Market
62.68%
IMGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMGN forecast to generate an efficient return on assets?
Company
17.84%
Industry
13.17%
IMGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMGN earnings per share forecast

What is IMGN's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
-$0.89
Avg 2 year Forecast
-$0.81
Avg 3 year Forecast
-$0.29

IMGN revenue forecast

What is IMGN's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$80.7M-15.56%
Avg 2 year Forecast
$136.9M+43.18%
Avg 3 year Forecast
$304.9M+218.94%
IMGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMGN revenue growth forecast

How is IMGN forecast to perform vs Biotechnology companies and vs the US market?
Company
43.15%
Industry
24.03%
Market
6.67%
IMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMGN$5.19$11.86+128.46%Buy
IOVA$7.17$24.00+234.73%Buy
ZNTL$19.75$44.86+127.12%Strong Buy
MDGL$65.24$138.33+112.04%Buy
VCEL$23.45$40.00+70.58%Buy

Immunogen Stock Forecast FAQ

Is Immunogen Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: IMGN) stock is to Buy IMGN stock.

Out of 7 analysts, 3 (42.86%) are recommending IMGN as a Strong Buy, 2 (28.57%) are recommending IMGN as a Buy, 2 (28.57%) are recommending IMGN as a Hold, 0 (0%) are recommending IMGN as a Sell, and 0 (0%) are recommending IMGN as a Strong Sell.

If you're new to stock investing, here's how to buy Immunogen stock.

What is IMGN's earnings growth forecast for 2022-2024?

(NASDAQ: IMGN) Immunogen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.05%.

Immunogen's earnings in 2022 is -$201,093,000.On average, 8 Wall Street analysts forecast IMGN's earnings for 2022 to be -$196,468,326, with the lowest IMGN earnings forecast at -$229,580,965, and the highest IMGN earnings forecast at -$181,015,761. On average, 8 Wall Street analysts forecast IMGN's earnings for 2023 to be -$178,808,252, with the lowest IMGN earnings forecast at -$231,788,474, and the highest IMGN earnings forecast at -$139,073,085.

In 2024, IMGN is forecast to generate -$64,017,769 in earnings, with the lowest earnings forecast at -$119,205,501 and the highest earnings forecast at $44,150,186.

What is IMGN's revenue growth forecast for 2022-2024?

(NASDAQ: IMGN) Immunogen's forecast annual revenue growth rate of 43.15% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.03%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.67%.

Immunogen's revenue in 2022 is $95,607,000.On average, 7 Wall Street analysts forecast IMGN's revenue for 2022 to be $17,820,780,916, with the lowest IMGN revenue forecast at $17,064,046,734, and the highest IMGN revenue forecast at $19,735,132,963. On average, 7 Wall Street analysts forecast IMGN's revenue for 2023 to be $30,217,932,281, with the lowest IMGN revenue forecast at $16,880,823,464, and the highest IMGN revenue forecast at $54,481,329,030.

In 2024, IMGN is forecast to generate $67,312,918,222 in revenue, with the lowest revenue forecast at $38,962,538,792 and the highest revenue forecast at $118,908,591,122.

What is IMGN's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: IMGN) forecast ROA is 17.84%, which is higher than the forecast US Biotechnology industry average of 13.17%.

What is IMGN's Price Target?

According to 7 Wall Street analysts that have issued a 1 year IMGN price target, the average IMGN price target is $11.86, with the highest IMGN stock price forecast at $20.00 and the lowest IMGN stock price forecast at $4.00.

On average, Wall Street analysts predict that Immunogen's share price could reach $11.86 by Nov 21, 2023. The average Immunogen stock price prediction forecasts a potential upside of 128.46% from the current IMGN share price of $5.19.

What is IMGN's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: IMGN) Immunogen's current Earnings Per Share (EPS) is -$0.82. On average, analysts forecast that IMGN's EPS will be -$0.89 for 2022, with the lowest EPS forecast at -$1.04, and the highest EPS forecast at -$0.82. On average, analysts forecast that IMGN's EPS will be -$0.81 for 2023, with the lowest EPS forecast at -$1.05, and the highest EPS forecast at -$0.63. In 2024, IMGN's EPS is forecast to hit -$0.29 (min: -$0.54, max: $0.20).

What is IMGN's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: IMGN) forecast ROE is 35.96%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.